≥2 ARMS/GROUPS: DICHOTOMOUS OUTCOMES (e.g. OR, RR, %death)

UI Author Year Outcome Exposure Categories(e.g., Tertiles)/Intervention Groups Mean Vit D level/dose Mean Ca level/dose No. of Cases (Event) * No. of Non- cases/Total N ** Crude or Adjusted analysis? Outcome Metric (e.g. OR, RR, HR, %) Outcome effect size CI/SE/SD ** P between groups *** P for trend ****
15671222 Hartman 2005 Recurrent adenomas Ca quintile 1 < 666 mg/d 156 nd Adjusted OR 1.0 0.20
Ca quintile 2 666– 814 163 nd Adjusted OR 1.12 0.83– 1.51
Ca quintile 3 815– 969 154 nd Adjusted OR 1.02 0.76– 1.38
Ca quintile 4 970– 1226 150 nd Adjusted OR 1.00 0.74– 1.36
Ca quintile 5 >1226 131 nd Adjusted OR 0.86 0.62– 1.18
15671222 Hartman 2005 Advanced adenomas Ca quintile 1 < 666 mg/d 23 nd Adjusted OR 1.0 0.98
Ca quintile 2 666– 814 26 nd Adjusted OR 1.19 0.66– 2.16
Ca quintile 3 815– 969 22 nd Adjusted OR 1.00 0.54– 1.85
Ca quintile 4 970– 1226 23 nd Adjusted OR 1.56 0.88– 2.77
Ca quintile 5 >1226 21 nd Adjusted OR 0.93 0.49– 1.79
15671222 Hartman 2005 Multiple recurrent adenomas Ca quintile 1 < 666 mg/d 58 nd Adjusted OR 1.0 0.36
Ca quintile 2 666– 814 73 nd Adjusted OR 1.33 0.90– 1.96
Ca quintile 3 815– 969 71 nd Adjusted OR 1.29 0.87– 1.92
Ca quintile 4 970– 1226 69 nd Adjusted OR 1.30 0.87– 1.93
Ca quintile 5 >1226 47 nd Adjusted OR 0.88 0.56– 1.36

Duplicate one row per exposure category or intervention group

*

Number of subjects with outcome

**

Please choose one and delete the others

***

Specify the comparison. For example group 1 vs. 3 = −6; group 1 vs. 2 = −8

****

P value for testing the linear trend of the OR/RR across different categories or doses

From: Appendix C, Evidence Tables: F-K

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.